Clinical trials: Rescue Emetic Therapy
Nausea, Vomiting
Emend for Multiple-day Emetogenic Chemotherapy
The purpose of the study is to assess the effect of Emend (aprepitant) on nausea and vomiting associated with chemotherapy. Chemotherapy commonly causes nausea and vomiting and this affects patients' quality of life and attitudes…
- Trial name
- NCT00711555
- Testing
- aprepitant, ondansetron, dexamethasone
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- University of Illinois Chicago